BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS; Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea. Diabetes Metab J 2019;43:398-406. [PMID: 31441247 DOI: 10.4093/dmj.2019.0137] [Cited by in Crossref: 98] [Cited by in F6Publishing: 71] [Article Influence: 49.0] [Reference Citation Analysis]
Number Citing Articles
1 Bae JH, Park EG, Kim S, Kim SG, Hahn S, Kim NH. Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Endocrinol Metab (Seoul) 2021;36:388-400. [PMID: 33789035 DOI: 10.3803/EnM.2020.912] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lee SH, Kim MK, Rhee EJ. Effects of Cardiovascular Risk Factor Variability on Health Outcomes. Endocrinol Metab (Seoul) 2020;35:217-26. [PMID: 32615706 DOI: 10.3803/EnM.2020.35.2.217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Seo D, Park YR, Lee Y, Kim JY, Park JY, Lee JH. The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study. J Med Internet Res 2020;22:e15372. [PMID: 32484447 DOI: 10.2196/15372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jain R, Awal H, Sen S. Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus. J Diabetes Complications 2020;34:107588. [PMID: 32345465 DOI: 10.1016/j.jdiacomp.2020.107588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Singh AK, Singh R, Chakraborty PP. Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes. Int J Gen Med 2021;14:3833-48. [PMID: 34335049 DOI: 10.2147/IJGM.S295459] [Reference Citation Analysis]
6 Kim MK, Han K, Cho JH, Kwon HS, Yoon KH, Lee SH. A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea. Diabetes Res Clin Pract 2020;163:108157. [PMID: 32333968 DOI: 10.1016/j.diabres.2020.108157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kim KJ, Kim NH, Choi J, Kim SG, Lee KJ. How Can We Adopt the Glucose Tolerance Test to Facilitate Predicting Pregnancy Outcome in Gestational Diabetes Mellitus? Endocrinol Metab (Seoul) 2021;36:988-96. [PMID: 34649416 DOI: 10.3803/EnM.2021.1107] [Reference Citation Analysis]
8 Ji L, Chan JCN, Yu M, Yoon KH, Kim SG, Choi SH, Huang CN, Te Tu S, Wang CY, Paldánius PM, Sheu WHH. Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective. Diabetes Obes Metab 2021;23:3-17. [PMID: 32991073 DOI: 10.1111/dom.14205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Cho SMJ, Lee H, Kim HC. Comparison and Implication of the Contemporary Blood Pressure Guidelines on Korean Population. Korean Circ J 2020;50:485-98. [PMID: 32212423 DOI: 10.4070/kcj.2019.0347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rhee EJ. Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets. Endocrinol Metab (Seoul) 2020;35:85-94. [PMID: 32207267 DOI: 10.3803/EnM.2020.35.1.85] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
11 Choi SY, Ko SH. Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus. Korean J Intern Med 2021;36:263-70. [PMID: 32872725 DOI: 10.3904/kjim.2020.327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chin SO, Ha IG, Rhee SY, Jeong SJ, Chon S, Kim SH, Ahn KJ, Baik SH, Park Y, Nam MS, Lee KW, Woo JT. Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes. Int J Endocrinol 2020;2020:9879517. [PMID: 32774367 DOI: 10.1155/2020/9879517] [Reference Citation Analysis]
13 Rhee EJ, Kim MK, Lee WY. Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020. Endocrinol Metab (Seoul) 2021;36:41-50. [PMID: 33677925 DOI: 10.3803/EnM.2021.106] [Reference Citation Analysis]
14 Cho SMJ, Lee H, Kim HC. Differences in prevalence of hypertension subtypes according to the 2018 Korean Society of Hypertension and 2017 American College of Cardiology/American Heart Association guidelines: The Korean National Health and Nutrition Examination Survey, 2007-2017 (KNHANES IV-VII). Clin Hypertens 2019;25:26. [PMID: 31819805 DOI: 10.1186/s40885-019-0129-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Sohn TS. Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9). Diabetes Metab J 2019;43:909-10. [PMID: 31902148 DOI: 10.4093/dmj.2019.0205] [Reference Citation Analysis]
16 Kim JJ, Yoon J, Lee YJ, Park B, Jung DH. Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans. Nutrients 2021;13:3231. [PMID: 34579107 DOI: 10.3390/nu13093231] [Reference Citation Analysis]
17 Lewandowski KC, Garnysz K, Horzelski W, Kawalec J, Budzen K, Grzesiak M, Lewinski A. Subclinical thyroid dysfunction in the first trimester of pregnancy: 'Disease' versus physiological (pulsatile) variation in TSH concentrations. Clin Endocrinol (Oxf) 2020;93:739-45. [PMID: 32430942 DOI: 10.1111/cen.14256] [Reference Citation Analysis]
18 Kim MK, Han K, Joung HN, Baek KH, Song KH, Kwon HS. Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease. Cardiovasc Diabetol 2019;18:139. [PMID: 31640795 DOI: 10.1186/s12933-019-0943-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
19 Kim NH, Kim SG. Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction. Diabetes Metab J 2020;44:213-21. [PMID: 32347023 DOI: 10.4093/dmj.2020.0001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
20 Bae J, Huh JH, Lee M, Lee YH, Lee BW. Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial. Diabetes Obes Metab 2021;23:609-18. [PMID: 33217092 DOI: 10.1111/dom.14259] [Reference Citation Analysis]
21 Qin J, Chen Y, Guo S, You Y, Xu Y, Wu J, Liu Z, Huang J, Chen L, Tao J. Effect of Tai Chi on Quality of Life, Body Mass Index, and Waist-Hip Ratio in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:543627. [PMID: 33542702 DOI: 10.3389/fendo.2020.543627] [Reference Citation Analysis]
22 Chung SM, Ahn JH, Moon JS. Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405-13). Diabetes Metab J 2020;44:625-6. [PMID: 32856805 DOI: 10.4093/dmj.2020.0167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kwon HS, Song KH, Yu JM, Kim DS, Shon HS, Ahn KJ, Choi SH, Ko SH, Kim W, Lee KH, Nam-Goong IS, Park TS. Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea. J Obes Metab Syndr 2021;30:261-70. [PMID: 34470918 DOI: 10.7570/jomes20137] [Reference Citation Analysis]
24 Kim J, Hur MH. The Effects of Dietary Education Interventions on Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2021;18:8439. [PMID: 34444187 DOI: 10.3390/ijerph18168439] [Reference Citation Analysis]
25 Kim HK, Lee M, Lee YH, Lee BW, Cha BS, Kang ES. Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes. Front Cardiovasc Med 2021;8:775753. [PMID: 34926623 DOI: 10.3389/fcvm.2021.775753] [Reference Citation Analysis]
26 Seo DH, Ha KH, Kim SH, Kim DJ. Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea. Endocrinol Metab (Seoul) 2021;36:70-80. [PMID: 33677929 DOI: 10.3803/EnM.2020.777] [Reference Citation Analysis]
27 Kim KS, Lee BW. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease. Clin Mol Hepatol 2020;26:430-43. [PMID: 32791578 DOI: 10.3350/cmh.2020.0137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
28 Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS; Committee of Clinical Practice Guidelines., Korean Diabetes Association and Committee of the Cooperative Studies., Korean Society of Nephrology. Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement. Kidney Res Clin Pract 2020;39:32-9. [PMID: 32138474 DOI: 10.23876/j.krcp.20.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Jeon D, Son M, Shim J. Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status. Nutrients 2021;13:1720. [PMID: 34069568 DOI: 10.3390/nu13051720] [Reference Citation Analysis]
30 Ha J, Lim Y, Kim MK, Kwon HS, Song KH, Ko SH, Kang MI, Moon SD, Baek KH. Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul) 2021;36:895-903. [PMID: 34365776 DOI: 10.3803/EnM.2021.1026] [Reference Citation Analysis]
31 Park B, Lee YJ, Lee HS, Jung DH. The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data. Cardiovasc Diabetol 2020;19:210. [PMID: 33302952 DOI: 10.1186/s12933-020-01186-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
32 Kim MJ, Lee EY, You YH, Yang HK, Yoon KH, Kim JW. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control. Stem Cell Res. 2020;48:101958. [PMID: 32882526 DOI: 10.1016/j.scr.2020.101958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
33 Kim MH, Oh HJ, Kwon SH, Jeon JS, Noh H, Han DC, Kim H, Ryu DR. Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study. Kidney Res Clin Pract 2021;40:660-72. [PMID: 34922433 DOI: 10.23876/j.krcp.20.222] [Reference Citation Analysis]
34 Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med 2020;18:361. [PMID: 33234146 DOI: 10.1186/s12916-020-01824-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
35 Lee SH, Han K, Kwon HS, Kim MK. Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes. Endocrinol Metab (Seoul) 2021;36:1007-15. [PMID: 34674499 DOI: 10.3803/EnM.2021.1218] [Reference Citation Analysis]
36 Koo BK, Moon S, Moon MK. Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study. BMC Geriatr 2021;21:684. [PMID: 34876063 DOI: 10.1186/s12877-021-02629-5] [Reference Citation Analysis]
37 Ahn J, Yang Y. Factors Associated with Poor Glycemic Control Amongst Rural Residents with Diabetes in Korea. Healthcare (Basel) 2021;9:391. [PMID: 33915834 DOI: 10.3390/healthcare9040391] [Reference Citation Analysis]
38 Kim KJ, Choi J, Bae JH, Kim KJ, Yoo HJ, Seo JA, Kim NH, Choi KM, Baik SH, Kim SG, Kim NH. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78). Diabetes Metab J 2021;45:617-8. [PMID: 34352991 DOI: 10.4093/dmj.2021.0152] [Reference Citation Analysis]
39 Kim MK, Han K, Koh ES, Hong OK, Baek KH, Song KH, Kwon HS. Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus. Diabetes Res Clin Pract 2021;175:108799. [PMID: 33845053 DOI: 10.1016/j.diabres.2021.108799] [Reference Citation Analysis]
40 Lee S, Ock M, Kim HS, Kim H. Effects of Co-administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case-Crossover Design. Pharmacotherapy 2020;40:902-12. [PMID: 33112454 DOI: 10.1002/phar.2450] [Reference Citation Analysis]
41 Yun JS, Park YM, Han K, Kim HW, Cha SA, Ahn YB, Ko SH. Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes. Sci Rep 2021;11:4305. [PMID: 33619302 DOI: 10.1038/s41598-021-82838-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kim YN, Kim DH, Shin HS, Lee S, Lee N, Park MJ, Song W, Jeong S. The risk factors for treatment-related mortality within first three months after kidney transplantation. PLoS One 2020;15:e0243586. [PMID: 33301510 DOI: 10.1371/journal.pone.0243586] [Reference Citation Analysis]
43 Lee KA, Jin HY, Kim YJ, Im YJ, Kim EY, Park TS. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019. J Korean Med Sci 2021;36:e230. [PMID: 34519186 DOI: 10.3346/jkms.2021.36.e230] [Reference Citation Analysis]
44 Kim WJ, Noh JH, Han K, Park CY. The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study. J Alzheimers Dis 2021;81:1263-72. [PMID: 33935082 DOI: 10.3233/JAD-201535] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Kim SW, Jeon JH, Moon JS, Kim MK. High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. Endocrinol Metab (Seoul) 2021;36:800-9. [PMID: 34418914 DOI: 10.3803/EnM.2021.1040] [Reference Citation Analysis]
46 Lee SH, Han K, Kim HS, Cho JH, Yoon KH, Kim MK. Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea. Endocrinol Metab (Seoul) 2020;35:636-46. [PMID: 32981306 DOI: 10.3803/EnM.2020.704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Lee DW, Moon MK; Committee of Clinical Practice Guideline, Korean Diabetes Association., Committee of the Cooperative Studies, Korean Society of Nephrology. Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement. Diabetes Metab J 2020;44:489-97. [PMID: 32856800 DOI: 10.4093/dmj.2020.0172] [Reference Citation Analysis]
48 Han SJ, Ha KH, Lee N, Kim DJ. Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study. Diabetes Obes Metab 2021;23:682-91. [PMID: 33236515 DOI: 10.1111/dom.14261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Jeon HL, Kim W, Kim B, Shin JY. Relationship between the early initiation of insulin treatment and diabetic complications in patients newly diagnosed with type 2 diabetes mellitus in Korea: A nationwide cohort study. J Diabetes Investig 2021. [PMID: 34825507 DOI: 10.1111/jdi.13719] [Reference Citation Analysis]
50 Yang E, Yoo H, Jang IJ, Yu KS, Lee S. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug Des Devel Ther 2021;15:651-8. [PMID: 33628012 DOI: 10.2147/DDDT.S288986] [Reference Citation Analysis]
51 Sen S. Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes. Diabetes Metab J 2019;43:744-51. [PMID: 31902144 DOI: 10.4093/dmj.2019.0175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Moon JS. Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8). Diabetes Metab J 2019;43:911-2. [PMID: 31902149 DOI: 10.4093/dmj.2019.0207] [Reference Citation Analysis]
53 Kim HU, Park SP, Kim YK. Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes. Sci Rep 2021;11:4731. [PMID: 33637847 DOI: 10.1038/s41598-021-84150-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, You JH, Lee JY, Hyun M, Park JS, Kwon YS, Choi YK, Kwon KT, Lee SY, Jeon EJ, Kim JW, Hong HL, Kwon HH, Jung CY, Lee YY, Ha E, Chung SM, Hur J, Ahn JH, Kim NY, Kim SW, Chang HH, Lee YH, Lee J, Park KG, Kim HA, Lee JH. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea. Diabetes Metab J 2020;44:602-13. [PMID: 32794386 DOI: 10.4093/dmj.2020.0146] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
55 Kim MK, Han K, You SY, Kwon HS, Yoon KH, Lee SH. Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy. Sci Rep 2020;10:13901. [PMID: 32807828 DOI: 10.1038/s41598-020-70873-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Yoon J, Jung D, Lee Y, Park B. The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes. J Pers Med 2021;11:742. [PMID: 34442386 DOI: 10.3390/jpm11080742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ji L, Bi Y, Ye S, Huang Y, Zhang X, Shang S, Cui N, Yin H, Zhang M. Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies. Diabetes Res Clin Pract 2021;176:108848. [PMID: 33945841 DOI: 10.1016/j.diabres.2021.108848] [Reference Citation Analysis]
58 Hur KY, Moon MK, Park JS, Kim SK, Lee SH, Yun JS, Baek JH, Noh J, Lee BW, Oh TJ, Chon S, Yang YS, Son JW, Choi JH, Song KH, Kim NH, Kim SY, Kim JW, Rhee SY, Lee YB, Jin SM, Kim JH, Kim CH, Kim DJ, Chun S, Rhee EJ, Kim HM, Kim HJ, Jee D, Kim JH, Choi WS, Lee EY, Yoon KH, Ko SH; Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metab J 2021;45:461-81. [PMID: 34352984 DOI: 10.4093/dmj.2021.0156] [Reference Citation Analysis]
59 Jang HN, Yang YS, Oh TJ, Koo BK, Lee SO, Park KS, Jang HC, Jung HS. Low fasting glucose-to-estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes. J Diabetes Investig 2021. [PMID: 34291584 DOI: 10.1111/jdi.13634] [Reference Citation Analysis]
60 Sheu WHH, Chan SP, Matawaran BJ, Deerochanawong C, Mithal A, Chan J, Suastika K, Khoo CM, Nguyen HM, Linong J, Luk A, Yoon KH. Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations. Diabetes Metab J 2020;44:11-32. [PMID: 32097996 DOI: 10.4093/dmj.2019.0208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
61 Min HK, Kim SH, Choi JH, Choi K, Kim HR, Lee SH. Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data. World J Clin Cases 2021; 9(33): 10198-10207 [PMID: 34904090 DOI: 10.12998/wjcc.v9.i33.10198] [Reference Citation Analysis]
62 Byun JI, Cha KS, Jun JE, Kim TJ, Jung KY, Jeong IK, Shin WC. Dynamic changes in nocturnal blood glucose levels are associated with sleep-related features in patients with obstructive sleep apnea. Sci Rep 2020;10:17877. [PMID: 33087786 DOI: 10.1038/s41598-020-74908-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
63 Kim G, Lim S, Kwon HS, Park IB, Ahn KJ, Park CY, Kwon SK, Kim HS, Park SW, Kim SG, Moon MK, Kim ES, Chung CH, Park KS, Kim M, Chung DJ, Lee CB, Kim TH, Lee MK. Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study). Diabetes Obes Metab 2020;22:1527-36. [PMID: 32319168 DOI: 10.1111/dom.14061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
64 Seo JA. An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready? Diabetes Metab J 2019;43:578-81. [PMID: 31694080 DOI: 10.4093/dmj.2019.0173] [Reference Citation Analysis]
65 Smyth A, Jenkins M, Dunham M, Kutzer Y, Taheri S, Whitehead L. Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management. Diabetes Research and Clinical Practice 2020;170:108532. [DOI: 10.1016/j.diabres.2020.108532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kim HW, Shin AY, Ha JH, Ahn JH, Kang HS, Kim JS. Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response - A retrospective cohort study. J Infect Chemother 2021:S1341-321X(21)00177-X. [PMID: 34238662 DOI: 10.1016/j.jiac.2021.06.016] [Reference Citation Analysis]
67 Lee BW, Lee YH, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH; Korean Diabetes Association (KDA) Fatty Liver Research Group. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes Metab J 2020;44:382-401. [PMID: 32431115 DOI: 10.4093/dmj.2020.0010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kim HC. Epidemiology of cardiovascular disease and its risk factors in Korea. Glob Health Med 2021;3:134-41. [PMID: 34250288 DOI: 10.35772/ghm.2021.01008] [Reference Citation Analysis]
69 Arafa A, Lee HH, Eshak ES, Shirai K, Liu K, Li J, Anni NS, Shim SY, Kim HC, Iso H. Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan. Korean Circ J 2021;51:643-55. [PMID: 34227266 DOI: 10.4070/kcj.2021.0121] [Reference Citation Analysis]
70 Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS; Committee of Clinical Practice Guidelines, Korean Diabetes Association., Committee of the Cooperative Studies, Korean Society of Nephrology. Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement. Diabetes Metab J 2020;44:3-10. [PMID: 32097995 DOI: 10.4093/dmj.2020.0004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
71 Jun JE, Kang H, Hwang YC, Ahn KJ, Chung HY, Jeong IK. The association between lipoprotein (a) and carotid atherosclerosis in patients with type 2 diabetes without pre-existing cardiovascular disease: A cross-sectional study. Diabetes Res Clin Pract 2021;171:108622. [PMID: 33316308 DOI: 10.1016/j.diabres.2020.108622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 You SY, Han K, Lee SH, Kim MK. Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes. Diabetol Metab Syndr 2021;13:90. [PMID: 34446090 DOI: 10.1186/s13098-021-00710-y] [Reference Citation Analysis]
73 Chung SM, Lee YY, Ha E, Yoon JS, Won KC, Lee HW, Hur J, Hong KS, Jang JG, Jin HJ, Choi EY, Shin KC, Chung JH, Lee KH, Ahn JH, Moon JS. The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study. Diabetes Metab J 2020;44:405-13. [PMID: 32602272 DOI: 10.4093/dmj.2020.0105] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
74 Lee SH, Han K, Kwon HS, Yoon KH, Kim MK. Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30-Day Mortality in the General Population. J Am Heart Assoc 2020;9:e017475. [PMID: 33153393 DOI: 10.1161/JAHA.120.017475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
75 Lee JH, Han JS, Han K, Lee SY. Association between Diabetes and the Use of Removable Dental Prostheses among the Korean Population. J Korean Med Sci 2019;34:e262. [PMID: 31650717 DOI: 10.3346/jkms.2019.34.e262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Euh W, Lim S, Kim JW. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:613389. [PMID: 34177796 DOI: 10.3389/fendo.2021.613389] [Reference Citation Analysis]
77 Kim K, Choi SH. Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea. Diabetes Metab J 2021;45:502-4. [PMID: 34352987 DOI: 10.4093/dmj.2021.0158] [Reference Citation Analysis]
78 Kim EH, Kim SS, Kim DJ, Choi YS, Lee CW, Ku BJ, Cha KS, Song KH, Kim DK, Kim IJ. A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study). Sci Rep 2020;10:19033. [PMID: 33149182 DOI: 10.1038/s41598-020-75594-5] [Reference Citation Analysis]
79 Jeon JY. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78). Diabetes Metab J 2021;45:613-4. [PMID: 34352989 DOI: 10.4093/dmj.2021.0129] [Reference Citation Analysis]
80 Bae J, Yoon JH, Lee JH, Nam JH, Lee CH, Son JW, Kim U, Park JS, Shin DG. Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes. Korean J Intern Med 2021;36:1365-76. [PMID: 34645114 DOI: 10.3904/kjim.2020.694] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Han E, Lee M, Lee YH, Kim HS, Lee BW, Cha BS, Kang ES. Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:4113-21. [PMID: 33173319 DOI: 10.2147/DMSO.S267994] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Chen KY, Liu YL, Shang JC, Su DW, Yao RR, Ke DZ, Tian H. Effect of roux-en Y gastric bypass surgery on patients with type 2 diabetes mellitus: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20382. [PMID: 32501984 DOI: 10.1097/MD.0000000000020382] [Reference Citation Analysis]
83 Lee JH, Chon S, Cha SA, Lim SY, Kim KR, Yun JS, Rhee SY, Yoon KH, Ahn YB, Woo JT, Ko SH; Korean Diabetes Prevention Study Investigators. Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea. Korean J Intern Med 2021;36:382-91. [PMID: 32114752 DOI: 10.3904/kjim.2019.171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Moon SJ, Yu KS, Kim MG. An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men. Clin Ther 2020;42:1047-57. [PMID: 32362346 DOI: 10.1016/j.clinthera.2020.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Ko S, Kim H, Shinn J, Byeon SJ, Choi JH, Kim HS. Estimation of sodium-glucose cotransporter 2 inhibitor-related genital and urinary tract infections via electronic medical record-based common data model. J Clin Pharm Ther 2021;46:975-83. [PMID: 33565150 DOI: 10.1111/jcpt.13381] [Reference Citation Analysis]
86 Chang MC, Hwang JM, Jeon JH, Kwak SG, Park D, Moon JS. Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study. Endocrinol Metab (Seoul) 2020;35:595-601. [PMID: 32842719 DOI: 10.3803/EnM.2020.719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
87 Jung CH, Son JW, Kang S, Kim WJ, Kim HS, Kim HS, Seo M, Shin HJ, Lee SS, Jeong SJ, Cho Y, Han SJ, Jang HM, Rho M, Lee S, Koo M, Yoo B, Moon JW, Lee HY, Yun JS, Kim SY, Kim SR, Jeong IK, Mok JO, Yoon KH. Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status. Diabetes Metab J 2021;45:1-10. [PMID: 33434426 DOI: 10.4093/dmj.2020.0254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
88 Ng JY, Verma KD, Gilotra K. Quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for type 2 diabetes mellitus: A systematic review. Nutr Metab Cardiovasc Dis 2021;31:3004-15. [PMID: 34627698 DOI: 10.1016/j.numecd.2021.07.029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Kim J, Lee M, Kim SY, Kim JH, Nam JS, Chun SW, Park SE, Kim KJ, Lee YH, Nam JY, Kang ES. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. Endocrinol Metab (Seoul) 2021;36:823-34. [PMID: 34474517 DOI: 10.3803/EnM.2021.1074] [Reference Citation Analysis]
90 Kim H, Lim DH, Kim Y. Classification and Prediction on the Effects of Nutritional Intake on Overweight/Obesity, Dyslipidemia, Hypertension and Type 2 Diabetes Mellitus Using Deep Learning Model: 4-7th Korea National Health and Nutrition Examination Survey. Int J Environ Res Public Health 2021;18:5597. [PMID: 34073854 DOI: 10.3390/ijerph18115597] [Reference Citation Analysis]
91 Lee EY, Yun JS, Cha SA, Lim SY, Lee JH, Ahn YB, Yoon KH, Ko SH. Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial. Int J Environ Res Public Health 2021;18:5300. [PMID: 34065775 DOI: 10.3390/ijerph18105300] [Reference Citation Analysis]
92 Kim J, Jeong K, Lee S, Seo BN, Baek Y. Low nutritional status links to the prevalence of pre-metabolic syndrome and its cluster in metabolically high-risk Korean adults: A cross-sectional study. Medicine (Baltimore) 2021;100:e25905. [PMID: 34011058 DOI: 10.1097/MD.0000000000025905] [Reference Citation Analysis]
93 Kalra S, A K D, Md F, K S, P S, A A R, M J, S S, A O, M R S, Selim S, M P B, Gangopadhyay KK, Y A L, T N, D D, S D T, V D, Dutta D, H K, R M, S D, A D, A B, G P, S C, Dhingra A, N P, A AA, M M. Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an International Expert Group (South Asia, Middle East & Africa) via modified Delphi method. Curr Med Res Opin 2021;37:403-9. [PMID: 33319626 DOI: 10.1080/03007995.2020.1864309] [Reference Citation Analysis]
94 Kim YK, Hwang JG, Park MK. No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects. Drug Des Devel Ther 2021;15:1725-34. [PMID: 33953542 DOI: 10.2147/DDDT.S302215] [Reference Citation Analysis]
95 Lee KA, Park TS, Jin HY. Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy. Endocrine 2020;70:465-78. [PMID: 32895875 DOI: 10.1007/s12020-020-02473-4] [Reference Citation Analysis]